Forecast on Yersinia Diagnostic Market for the Period 2013 - 2019

Yersinia is a gram positive rod shaped bacteria belonging to the family Enterobacteriaceae that mostly causes enterocolitis, terminal iletis, acute diarrhea, mesenteric lymphadenitis, psediappendicitis and sepsis. Yersinia is a food borne bacteria that enters in the human body through unhygienic, canned and stale food. Pigs are the major animal reservoir of Yersinia but strains are also found in rodents, sheep, cattle, dogs, rabbits, cats and horses. The bacteria enter into the human beings through these animals.

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/yersinia-diagnostic-market.html

Clinical signs for diagnosis of Yersinia infection include low grade fever, diarrhea, abdominal pain and vomiting. The patient sometimes also develops erythmanodosum which results in painful red or purple lesions on the patient’s legs. These lesions are visible after 2 to 20 days post the onset of fever and abdominal pain. Yersinia usually occurs in children and is second most common cause of bacterial gastrointestinal infection. Yersinia infections affect men three times more than women but post-infectious complications of arthritis and nodosum are more common in women.

For curing Yersinia infection, patient needs to take good care of their nutrition and hydration during the treatment. Treatment of the infection includes administration of cephalosporins, tetracyclines, trimethoprim-sulfamethoxasole (TMP-SMZ), Fluoroquinolones and aminoglycosides. If the condition worsens and patient is diagnosed with complications such as peritoneal findings, acute abdominal presentations or uncommon intussusceptions, gastroenterologists perform exploratory laparotomy. The Centers of Disease Control and Prevention (CDC) have taken the responsibility to monitor the frequency of Yersinia enterocolitica infection with the help of foodborne disease active surveillance network called FoodNet. In addition CDC also conducts awareness programs and investigations to control this infection.

Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2154

North America currently leads the Yersinia diagnostics market due to relatively high incidence rate of Yersinia infection and presence of sophisticated healthcare infrastructure coupled with initiatives undertaken by the domestic governments. The European market is for Yersinia diagnostics is mainly driven by the high prevalence of disease in Scandinavian countries. On the other hand, high presence of untapped opportunities in the emerging economies of Asia-Pacific and high prevalence of Yersinia infection in Japan are some of the key factors responsible for growth in Asia-Pacific. The major players in the Yersinia diagnostics market include Abbott Laboratories, Bio-Rad Laboratories, Becton Dickinson, Gen Probe, Danaher Corporation, Hologic Roche and Affymetrix, Inc.

Pre Book this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=2154<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.